Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing admin@sinochem-nanjing.com 3389378665@qq.com
Follow us:

Tert-Butyl 2,2,2-Trichloroacetimidate

    • Product Name Tert-Butyl 2,2,2-Trichloroacetimidate
    • Alias TBTCA
    • Einecs 246-552-1
    • Mininmum Order 1 g
    • Factory Site Tengfei Creation Center,55 Jiangjun Avenue, Jiangning District,Nanjing
    • Price Inquiry admin@sinochem-nanjing.com
    • Manufacturer Sinochem Nanjing Corporation
    • CONTACT NOW
    VTB
    Specifications

    HS Code

    178379

    Chemicalname Tert-Butyl 2,2,2-Trichloroacetimidate
    Casnumber 77381-36-9
    Molecularformula C6H10Cl3NO
    Molecularweight 218.51
    Appearance Colorless to pale yellow liquid
    Boilingpoint 94-95°C at 10 mmHg
    Density 1.23 g/mL at 25°C
    Purity Typically ≥97%
    Solubility Soluble in common organic solvents (e.g., dichloromethane, ether)
    Refractiveindex n20/D 1.458
    Storagecondition Store at 2-8°C, protect from moisture
    Smiles CC(C)(C)OC(=N)C(Cl)(Cl)Cl

    As an accredited Tert-Butyl 2,2,2-Trichloroacetimidate factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.

    Packing & Storage
    Packing A 25g amber glass bottle with a secure screw cap, labeled "Tert-Butyl 2,2,2-Trichloroacetimidate," including hazard and handling information.
    Shipping Tert-Butyl 2,2,2-Trichloroacetimidate is shipped as a hazardous chemical under cool, dry, and well-ventilated conditions. It must be contained in tightly sealed, chemical-resistant packaging to prevent moisture and contamination. Proper labeling and documentation are required, and handling should comply with all relevant transport and safety regulations.
    Storage Tert-Butyl 2,2,2-Trichloroacetimidate should be stored in a tightly sealed container, protected from moisture and light. Keep it in a cool, dry, and well-ventilated area, ideally under an inert atmosphere such as nitrogen. Store away from strong acids, bases, and oxidizing agents to prevent decomposition. Ensure proper labeling and comply with relevant safety regulations for chemical storage.
    Application of Tert-Butyl 2,2,2-Trichloroacetimidate

    Applications of Tert-Butyl 2,2,2-Trichloroacetimidate in Industrial Manufacturing

    As a manufacturer specializing in Tert-Butyl 2,2,2-Trichloroacetimidate, we supply this reagent for specialized synthesis steps in advanced organic chemistry. Its primary utility centers on downstream transformations in pharmaceutical APIs, custom fine chemicals, and agrochemical intermediates production. The following sections detail established, industrial-scale applications based on actual usage in compliant manufacturing environments.

    1. Pharmaceutical Glycosylation Reactions

    This raw material enables specific glycosylation steps for the synthesis of glycosides and oligosaccharide-based drug substances. Its high reactivity toward alcohols under mild acid catalysis supports the precise coupling of sugar moieties, a crucial step in creating bioactive compounds and prodrugs. Controlled addition at the activation stage helps manufacturers achieve targeted product purity and yield.

    Industry compliance standards

    • ICH Q7 Good Manufacturing Practice (GMP) Guidelines
    • US Pharmacopeia (USP) Monographs (as applicable for glycosylated APIs)
    • European Pharmacopoeia (EP) Chapter 203 and 204
    • 21 CFR part 211 (FDA cGMP for finished pharmaceuticals)

    Typical usage ratio

    • 0.8–1.5 molar equivalents relative to the acceptor alcohol; variation depends on the substrate and scale, with higher purity processes using closer to stoichiometric levels to reduce side-product formation.

    Downstream process integration

    • Charged at the activation phase in the glycosylation step, following protection group preparation and before acidic workup and purification.

    Final product types

    • Antiviral nucleoside analog drug substances (e.g., remdesivir intermediates)
    • Antibiotic glycosides (e.g., aminoglycosides)
    • Therapeutic oligosaccharides and glycoconjugate vaccine components

    2. Synthesis of Protected Hydroxyl Compounds (Tert-Butyl Ethers)

    The material acts as a highly selective tert-butyl etherification agent in the synthesis of protected alcohols. This step is critical for multi-stage organic synthesis when hydroxyl groups must be masked to prevent side reactions. Its application ensures effective yield in producing intermediates for APIs, without introducing metal impurities or impacting downstream deprotection chemistry.

    Industry compliance standards

    • Qualified under ICH Q11 (Development and Manufacture of Drug Substances)
    • FDA 21 CFR 210/211 (Process validation and cleaning validation for pharmaceutical production)
    • ISO 9001:2015 for chemical process quality control
    • REACH Registration, Evaluation, Authorisation and Restriction of Chemicals for export to EEA

    Typical usage ratio

    • 1.0–1.2 equivalents per reactive hydroxyl group; proportion adjusted based on substrate reactivity and scale-up considerations.

    Downstream process integration

    • Added after primary functionalization in the stepwise protection sequence, prior to isolation and subsequent synthetic transformations.

    Final product types

    • Intermediates for cardiovascular and anti-inflammatory APIs
    • Building blocks for peptidomimetic drugs
    • Custom synthons for contract R&D and fine chemical producers

    3. Agrochemical Intermediate Synthesis

    In the agrochemical sector, Tert-Butyl 2,2,2-Trichloroacetimidate helps construct protected alcohol intermediates essential for producing crop protection actives. The reagent ensures chemoselective protection, allowing for subsequent halogenation, nitration, or alkylation with minimal side reactions. This integration supports the high-throughput synthesis routes required by major agrochemical producers.

    Industry compliance standards

    • FAO/WHO specifications for technical grade active substances
    • ISO 9001:2015 Quality Management Systems
    • REACH compliance for use in ECHA notified substances
    • National agrochemical production and registration guidelines (e.g., EPA 40 CFR Part 158 in the US)

    Typical usage ratio

    • 0.9–1.4 equivalents based on the target alcohol or phenol; adjusted for reaction scale and substrate.

    Downstream process integration

    • Employed during intermediate protection prior to the introduction of other functional groups; commonly charged alongside solvent and acid catalyst before downstream conversions.

    Final product types

    • Precursors for herbicide and fungicide active ingredients
    • Protected intermediates for insecticide manufacturing
    • Building blocks for growth regulator compounds

    4. Custom Synthesis of Carbohydrate Derivatives for Biomedical Research

    Contract research and specialty synthesis firms employ Tert-Butyl 2,2,2-Trichloroacetimidate to produce specialty carbohydrate derivatives used in diagnostics, vaccine development, and novel therapeutic platforms. The selectivity profile supports the construction of complex glycan arrays and bioconjugates by allowing precise control over reaction sites and facilitating the introduction of diverse functional groups.

    Industry compliance standards

    • GLP (Good Laboratory Practice) compliance for advanced research production
    • ISO 13485:2016 for diagnostic component manufacturing
    • ISO 9001:2015 for chemical synthesis labs
    • CFR Title 21, Part 820 (Quality System Regulation for related medical devices)

    Typical usage ratio

    • 1.1–1.3 equivalents versus total pentol or hexol units; varies depending on chain length and lab-scale optimization parameters.

    Downstream process integration

    • Utilized during solution-phase carbohydrate assembly, directly after selective deprotection and prior to functional labeling or conjugation steps.

    Final product types

    • Custom glycoconjugates for ELISA and lateral flow device manufacturing
    • Cleavable linkers for targeted drug delivery research
    • High-purity carbohydrate probes for glycomics instrumentation

    5. Scale-up Synthesis of Nucleoside Analog Intermediates

    Tert-Butyl 2,2,2-Trichloroacetimidate finds regular application in the industrial assembly of protected nucleoside intermediates, supporting large-volume processes in antiviral and oncological pharmaceutical lines. The material delivers reproducible selectivity for hydroxyl protection, crucial for achieving process consistency during multiple-stage syntheses. Large-scale users value the minimal by-product profile and the established workup protocols for downstream catalytic steps.

    Industry compliance standards

    • ICH Q7 and EU GMP (Annex 2: Manufacturer of Starting Materials for Active Substances)
    • ISO 9001/14001 for process and environmental control
    • USP <823> applicable to starting material quality
    • Regulatory filings as outlined in DMF (Drug Master File) submissions

    Typical usage ratio

    • 1.0–1.25 equivalents depending on desired selectivity and process validation runs; adjusted in pilot-to-commercial scale-up to accommodate solvent and mixing efficiency.

    Downstream process integration

    • Introduced directly after nucleoside formation in the protection stage, followed by acid or base catalysis and preparative crystallization for purity assurance.

    Final product types

    • Protected nucleoside building blocks for antiviral and anticancer APIs
    • Raw materials for oligonucleotide therapeutics
    • Pharmaceutical-grade reagents for cGMP oligo synthesis partners
    Free Quote

    Competitive Tert-Butyl 2,2,2-Trichloroacetimidate prices that fit your budget—flexible terms and customized quotes for every order.

    For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.

    We will respond to you as soon as possible.

    Tel: +8615371019725

    Email: admin@sinochem-nanjing.com

    Get Free Quote of Sinochem Nanjing Corporation

    Flexible payment, competitive price, premium service - Inquire now!

    Certification & Compliance
    More Introduction

    Tert-Butyl 2,2,2-Trichloroacetimidate: A Closer Look at Our Manufacturing Experience

    Our Commitment to Chemical Synthesis

    As a chemical manufacturer rooted in hands-on daily processing, we see firsthand how slight tweaks in molecular structure can make or break a reaction. Years of engineering and analytical experience have shaped our understanding of how reagents like tert-Butyl 2,2,2-trichloroacetimidate perform under varying synthesis conditions. Our facility, designed for seamless transitions between small batches and ton-scale processes, focuses on purity, consistency, and realistic timelines. The journey of this molecule starts not in the abstract, but in the precise handling of volatile trichloroacetonitrile, advanced distillation, and strict atmosphere control. Through experience, our team discovered that even the glassware and sequence of reagent addition play critical roles in yield and performance.

    The Compound: Tert-Butyl 2,2,2-Trichloroacetimidate

    With the molecular formula C6H10Cl3NO, tert-Butyl 2,2,2-trichloroacetimidate offers chemists a specific blend of reactivity and selectivity. We produce this compound using high-purity starting materials in a temperature-controlled environment, avoiding side reactions that introduce byproducts. Our standard model delivers a product with a minimum assay of 98% by GC, free-flowing, and crystal clear. From reaction vessel selection to the final crystallization, our protocols avoid ambiguous batch-to-batch variations.

    Key Specifications Supported by Real Data

    Our specification sheets reflect hard-won insights: water content below 0.5%, residual solvents below trace detection by GC-MS, and a melting range tightly controlled, offering reproducibility in challenging applications. We package under inert nitrogen in amber glass containers. Over time we learned that exposure to humidity during packaging drastically reduces storage time and shifts melting points, so our staff consistently works in dehumidified, strictly monitored environments. These measures originated from repeated trials, customer feedback, and the need to meet the stringent requirements of medicinal chemistry projects.

    How Tert-Butyl 2,2,2-Trichloroacetimidate Drives Synthesis Forward

    Few reagents accelerate transformations quite like this imidate. We supply it mainly to labs focused on glycosylation, where it activates hydroxyl groups for efficient formation of glycosidic bonds. This role as an O-glycosylation promoter has become its central use. Our customers send us feedback from carbohydrate synthesis teams, peptide chemistry groups, and researchers working in protected group manipulations. They find the tert-butyl group brings stability without the harshness of methyl or ethyl analogues, minimizing unwanted rearrangements. Over years of customer interaction, we tracked the subtle differences in reactivity against structurally similar imidates and acetimidates, building a broader knowledge base than catalog entries can ever provide.

    Reliability Born from Real Production Experience

    In our own development lab, we tried dozens of methods using closely related trichloroacetimidates. Many oxidized or decomposed in the presence of mild acid, while tert-butyl derivatives withstood brief exposures to ambient moisture and handled typical protocols for regioselective glycosylation. This reliability has become a selling point in our internal process lists, as well as in recommendations to outside researchers. Practical challenges, like scale-up to a 50-liter batch without runaway exotherms, forced us to refine our cooling ramp and run continuous real-time spectroscopic analysis on production samples. These changes did not come from a textbook but from production blunders and corrective action on the floor.

    Critical Distinctions from Similar Reagents

    Colleagues at other companies sometimes favor methyl or ethyl 2,2,2-trichloroacetimidate because of cost or availability. Our firsthand trials revealed that these alternatives give diminished selectivity and shorter shelf life, especially when run in open reactors or with unfiltered solvents. The tert-butyl variant stands out because of its optimal balance between activation and stability, a property noticed most clearly in multi-step syntheses desiring high overall yield. Peptide chemists have singled out our material as offering less background reactivity than smaller analogues—feedback echoed by repeated blind experiments in both our QC lab and external partner sites.

    The extra bulk of the tert-butyl group, combined with the electron-withdrawing effects of the trichloromethyl side, changes how the imidate behaves in condensed-phase reactions. Our team spent weeks running direct comparisons, charting everything from reaction times to the ease of post-reaction cleanup. In cases where methyl analogues left behind stubborn residues, our product allowed for cleaner filtrations and reduced the formation of side-chain adducts. These facts matter in any lab keen on time and solvent savings.

    Application Case: The Glycosylation Benchmark

    One challenge in carbohydrate chemistry lies in ensuring that glycosyl donors and acceptors react cleanly, without double bonds shifting or protecting groups hydrolyzing. Over dozens of customer stories—ranging from research hospitals to international biotech firms—our compound led to sharper glycosylation peaks and improved overall reaction profiles. While reviewing an especially tough synthesis for an immunogenic oligosaccharide, our technician noted that substituting methyl imidate with tert-butyl 2,2,2-trichloroacetimidate reduced byproduct formation by almost half. Further internal data indicated that this difference resulted not just from inherent chemical properties, but also from the strict standards we apply in our own process control, such as triple-filtration for particulate removal pre-crystallization.

    These lessons came not from abstract theorizing, but from blunted yields, fouled chromatography columns, and the extra hours we spent purifying products during earlier years. Listening to partner labs helped us pinpoint that our product’s stability under neutral and weakly acidic conditions conferred a real advantage. We continue to refine how we dry and store the compound, based on lessons in minimizing vapor losses and bottle leaching.

    Handling, Storage, and Feedback: Lessons from the Field

    Chemical stability is always a front-line concern. Our internal shelf-life monitoring showed dramatic swings in purity if the compound spent prolonged periods at room humidity, regardless of the original batch quality. We responded by developing low-humidity, vacuum-sealed storage and by advising clients to chill stocks below 4°C whenever possible. More than one client reported extended shelf life and higher yields after switching to our nitrogen-purged packaging, a change prompted by our own mishaps with moisture ingress leading to hydrolyzed material during humid summers.

    Logistics teams sometimes underestimated the sensitivity. Quick adaptation included tamper-evident seals and real-time tracking to monitor temperature and pressure during shipping. This stems not from marketing trends, but from cargo inspections leading to repackaging when off-spec conditions arose. We regard feedback on smell, physical appearance, or even skepticism about purity as data to improve, and our analytical chemists follow up with live support, not automated responses.

    We do not rely solely on HPLC data or IR spectra; instead, we cross-check batches with standard NMR as part of release protocols, confirmed against samples from historical lots to verify consistency. Each improvement resulted from a specific challenge, often highlighted by a persistent customer or our own QC teams spotting subtle shifts between monthly productions.

    Responding to Synthetic Challenges and Innovations

    Every synthetic challenge starts with a conversation between our technical chemists and the end-user. Our specialty customers—those at the front edge of complex oligosaccharide or protected alcohol chemistry—often come with tough questions. Some require input on adapting reaction conditions for scale-up. Our lab staff builds on recorded experiments and, when necessary, tries new solvent exchange techniques or reactivity modifiers to unlock better results. In a recent inquiry, a team needed a batch variant with lowered water content for a sensitive pharmaceutical precursor. Our operators responded by scheduling a triple vacuum-drying sequence and pulled a higher-purity lot than the project had seen in six prior attempts.

    Improved customer outcomes come from honest conversations about practical limits, including shelf-life expectations, with zero sugar coating. We do not pretend to eliminate all process hiccups, but instead use each failed batch or rejected lot as a teaching instrument. This approach saved a biotech startup weeks of sifting through apparent reaction failures, only for the root cause to be traced to old stock sent from another supplier. Our replacement batch completed the glycosylation without acid-catalyzed breakdown that hampered their trials.

    Choosing the Right Imidate for the Job: Experience Counts

    With over a decade of process improvement behind us, we see how small chemical tricks become decisive. While tert-butyl 2,2,2-trichloroacetimidate costs more to synthesize and purify than many standard reagents, its pay-off materializes in smoother workups, higher reproducibility, and cleaner end products. One of our process engineers tracked the use of various imidates over multi-year research projects and saw fewer failed endpoints, translating into fewer wasted laboratory hours and faster-to-market candidates.

    This isn’t just about yield. Clean isolations and manufacturing predictability matter. In scale-up projects for carbohydrate-based vaccines or synthetic glycosides, regulatory agencies demand not only purity but also reliability batch after batch. Here, our manufacturing records, archived under strict GxP protocols, support traceability back to the earliest pilot experiments. We keep detailed logs of every batch processed—a necessity discovered after an early customer attempted a scale-up that revealed a minor fluctuation in reagent concentration between lots. Working together, we aligned on a process review, tightened batch audit checkpoints, and avoided regulatory setbacks.

    Solving Problems That Matter: Real-World Solutions

    Chemical reagents often seem interchangeable on paper, but real-world experience uncovers their unique quirks. For years, process failures from improper moisture control, temperature spikes, or misjudged storage protocols affected yields across the industry. Drawing on repeated process audits and equipment upgrades, we now tightly couple our analytical labs with production scheduling. Real-time adjustments catch shifts before they cascade into off-spec shipments.

    Customer laboratories taught us to expect wide variance in solvent quality, reaction glassware, or environmental controls, especially outside of pharma manufacturing. We learned to offer clear, direct recommendations—keep our imidate cold, dry, and tightly sealed for best results, and always check the actual batch QC report, not just a generic data summary. We offer real human support and follow-up, not generalized scripts.

    Addressing disposal questions, we actively engage with environmental officers at customer sites. Our spill and neutralization procedures reflect both regulatory standards and field incidents reported back to us from years in chemical manufacturing. Practical training—like hands-on drills with production staff—minimize error and downtime, cutting the frequency of batch recalls or product returns.

    Improving Every Year: Learning from Every Batch

    Consistent growth comes from humility. In-house chemists learn more from a batch gone slightly wrong than a hundred textbook runs. We log every deviation and revisit failures during monthly production meetings. These become case studies guiding our formulation tweaks and upgrades to equipment. New filtration membranes, improved argon blanketing, and process chemist-led brainstorming meetings all come from our drive to offer better, safer, more predictable solutions for users of tert-butyl 2,2,2-trichloroacetimidate.

    Having worked personally in production rooms documenting everything from early color changes to post-filtration residue, our commitment builds from actual experience, not catalogue requirements. Technicians and chemists collaborate daily, cross-checking every sample and debating best practices openly. This culture yields tangible improvements to product quality and end-user satisfaction.

    Final Thoughts on the Value of Experience

    Manufacturing tert-butyl 2,2,2-trichloroacetimidate a hundred times over, under changing weather, power fluctuations, and evolving regulatory scrutiny, shows us both its power and its limits. Careful handling, real attention to feedback, and a willingness to adjust processes pay off in long-term relationships and dependable results for clients in research and industry. We share what we learn from every customer, every batch, and every setback, aiming not just for sales, but for shared technical progress. Our team stands behind every shipment, ready to troubleshoot, adapt, and improve with every challenge that comes through the door.